PulteGroup PHM
Consumer Cyclical · Residential Construction · Synthos Deep Dive · 2026-07-03
The Overview
PulteGroup builds houses — around 30,000 homes a year under brands like Pulte, Centex, and Del Webb (the 55-and-over communities). It also runs a small mortgage and title arm for its buyers.
Is the stock cheap or expensive? On the surface it looks cheap — you pay about $12.50 for every $1 of last year's profit, versus $20-plus for the average big company. But there's a catch that's easy to miss: homebuilder profits go up and down with the housing cycle, and PulteGroup's profits are already falling (higher mortgage rates and buyer worries about affordability are forcing the company to cut prices and pile on incentives). A cheap-looking price on top of shrinking earnings is a classic cyclical trap, so "cheap" here is not the free lunch it looks like.
Our verdict is Watch — a good, financially sturdy company, but there's no clear bargain today and the near-term wind is in its face.
Here's what our three scores mean in everyday terms:
- Downside Risk 4/10 (a bit safer than average). The balance sheet is rock-solid (almost no net debt) and the stock is cheap, which cushions the fall — but house-building swings hard with the economy, so it's riskier than a steady-eddie business.
- Growth Quality 4/10 (below average right now). Profits are shrinking this year, and the company keeps less of each sales dollar than it did a year ago. What saves the score: it earns good returns and shrinks its share count aggressively.
- Exponential Potential 2/10 (low). This is a mature, up-and-down industry. Don't expect it to grow like a tech company — expect it to ride the housing cycle.
The one big worry: the housing cycle. If mortgage rates stay high or the economy weakens, both the number of homes sold and the profit per home can fall together — which is exactly what's happening now.
Putting a number on it: our fair-value estimate is $134 against a current price of $128.55 — real upside if our numbers are right.
Our summary metrics
Cheap (12.5× TTM) & fortress balance sheet (net-debt/EBITDA 0.21×) — but beta 1.2, deeply cyclical, margins compressing.
EPS falling −11% into FY26 trough, gross margin 27.5%→24.4%; strong 16% ROE & disciplined buyback offset a low ~6% forward EPS CAGR.
Mature, decelerating cyclical — no acceleration, capped TAM; a housing-cycle compounder, not an exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Mature, decelerating cyclical — no acceleration, capped TAM; a housing-cycle compounder, not an exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $144.5 (high $162 / low $115; 0 Strong-Buy · 20 Buy · 21 Hold · 3 Sell → Hold) — context, not our anchor |
| Valuation | 12.5× TTM EPS · 13.4× FY26E · 12.0× FY27E · 10.1× FY28E · EV/EBITDA 9.3× · EV/S 1.5× · P/B 2.0× |
| Technicals | Uptrend — $133.67, −6% off 52-wk high, above 50/200-DMA, RSI 66, +21.6% 12-mo (SPY +20.6%) |
| Conviction | None (quant-only) — 0 expert voices, 0 KB claims. This is a data-driven note. |
| Position sizing | If owned at all, a small cyclical/value satellite (~1–2%), sized to survive a housing downturn |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for PHM — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $128.55, 1% below the 50-day average ($129), 3% above the 200-day average ($125) — a mixed trend. 10% below the 52-week high of $143, 17% above the 52-week low of $110.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $128.55 is currently inside the band (band $126–$133).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 49.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.28, negative momentum.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = PHM · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
PulteGroup, Inc. (NYSE: PHM) is one of the largest U.S. homebuilders, operating in 45+ markets under Centex (entry-level), Pulte Homes and DiVosta (move-up), Del Webb (active-adult / 55+), and John Wieland Homes (luxury). The model is land-light-ish for the industry: acquire and develop land, build to order plus some spec inventory, and cross-sell mortgages and title through a small Financial Services arm. Headquartered in Atlanta; fiscal year ends December 31.
Revenue mix (FY2025, from filings):
- By segment: Home Building $16.92B (97.8%) · Financial Services $0.39B (2.2%). This is a pure homebuilder — the mortgage arm is a support function, not a profit engine (Q1'26 financial-services pre-tax income was just $13M).
- By geography (Home Building): West $3.88B · Florida $4.26B · Southeast $2.96B · Midwest $2.73B · Texas $1.68B · Northeast $1.24B. Heavy Sun Belt / Florida concentration — a demand tailwind over the past decade, but also exposure to Florida insurance costs, property-tax/affordability pressure, and any regional oversupply.
The strategic frame that matters: PHM is running a disciplined, returns-focused playbook — average selling price ~$542K (Q1'26), a mix of spec and build-to-order, and heavy return of capital (buybacks) rather than chasing volume into a soft market.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of PHM in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0, and the top claims array is empty. No investor, analyst, or operator in our tracked panel has an on-the-record, distilled view on PulteGroup.
Because fabricating conviction is against the house standard, this note carries zero borrowed conviction. Every judgment below is derived from the primary financials (FMP), management's own earnings release (SEC 8-K, §9, half-weighted), and quantitative valuation — not from any expert claim. Where you would normally see a claim_id citation, there is deliberately none. The verdict is fundamentals- and quant-driven.
This absence is itself information: PHM is not a name our high-skill panel is talking about. That is consistent with a mature, well-understood cyclical rather than a contested or emerging story.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 4 · Moderate-Low | Cheap (12.5× TTM, EV/EBITDA 9.3×) and a fortress balance sheet (net-debt/EBITDA 0.21×, debt/capital 12.3%, current ratio 5.5×) limit blow-up risk — but beta 1.2, deep cyclicality, and compressing margins (home-sale GM 27.5%→24.4% YoY) mean earnings can fall fast in a downturn. |
| Growth Quality | 4 · Below-Average (cyclically) | EPS is falling — $14.82 (FY24) → $11.21 (FY25) → ~$10.00 (FY26E) — and gross margin is eroding. Offsets: 16% ROE, 13% ROIC, ~5% annual buyback yield, and an eventual FY27–28 recovery. Quality company, poor moment in the cycle. |
| Exponential Potential | 2 · Low | Revenue CAGR ~2% and EPS CAGR ~6% FY25→FY28E, and growth is decelerating into a trough, not accelerating. Mature industry, capped TAM, $25B cap. This is a cyclical, not an exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Mortgage rates ease, affordability improves, incentives roll off; volumes and margins re-expand. FY27E EPS beats to ~$13.2 (vs $11.13 cons) and the market pays a cyclical-recovery ~14×. | ~$185 (+38%) |
| Base (our anchor) | Estimates roughly hit — FY26 EPS troughs ~$10.0, FY27E recovers to $11.13; a disciplined homebuilder off a trough earns a mid-cycle ~12×. | ~$134 (~flat) |
| Bear | Rates stay high / recession; volumes and gross margin both compress further. FY27E EPS misses toward ~$9.5 and the multiple de-rates to a downturn ~9–10× (still above tangible book ~$67). | ~$95 (−29%) |
Synthos fair value = the base case, ~$134 (roughly flat to spot), with the full $95–$185 span as the honest range. Note the base sits below the Street's $144.5 consensus — we are less willing to underwrite a clean cyclical recovery multiple while margins are still falling. This is a tracked call — the Forecaster Scorecard grades it once it matures. The wide, roughly-symmetric range around spot is exactly why the verdict is Watch, not Buy: the market has already priced a fair mid-cycle outcome.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). PHM is neither at present — it is a well-run cyclical near a cyclical earnings peak-turning-lower:
- Forward growth: revenue CAGR FY25→FY28E ~2.2% ($17.3B → $18.5B est); EPS CAGR ~5.6% ($11.21 → $13.18 est) — but that "growth" is really a recovery off a FY26 trough, not secular expansion.
- Acceleration (the 2nd derivative) is negative into 2026: EPS growth −10.8% (FY26E) before rebounding +11.3% (FY27E) and +18.5% (FY28E). The near-term trend is deceleration; the out-years are a cyclical bounce off a low base, not an accelerating growth engine.
- Room to run: the U.S. new-home market is large but mature and supply-constrained by land, labor, and rates — not a greenfield TAM. At $25B cap in a fragmented but consolidated industry, there is no realistic path to a multibagger from organic growth.
- Reinvestment runway: management is deliberately not plowing everything back into growth — it invested $1.3B into land in Q1'26 but returned $360M to shareholders and expanded the buyback authorization by $1.5B. That is the right call for a mature cyclical, but it confirms this is a capital-return story, not a compounding-growth story.
Exponential Potential: Low (2/10). Own PHM (if at all) for cheap cyclical value + aggressive buybacks, not for growth. The honest framing keeps it out of any "next exponential" sleeve.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $17.31B, −3.5% (FY24 $17.95B; FY23 $16.06B). Top line is flat-to-down — a mature cyclical plateau, not growth.
- Quarterly trajectory (the cyclical tell): Q1'25 $3.89B → Q2 $4.40B → Q3 $4.40B → Q4 $4.61B → Q1'26 $3.41B (−12% YoY). Closings −7% and average selling price −5% YoY in Q1'26 — both volume and price softening together.
- Margins (compressing — the key concern): home-sale gross margin 24.4% Q1'26 vs 27.5% a year ago; TTM gross margin 26.1%, EBITDA margin 16.6%, net margin 12.1%. Higher incentives to clear spec inventory are eating margin.
- Earnings: net income $2.22B FY25 (down from $3.08B FY24); EPS $11.21 (from $14.82). Q1'26 net income $347M, EPS $1.79 (vs $2.57 a year ago). The earnings cycle has clearly rolled over.
- Cash flow: operating CF ~$1.87B, capex only ~$123M (asset-light build), FCF ~$1.75B FY25 (10.7% margin, ~6.5% FCF yield). Cash generation remains healthy even as earnings dip — a cyclical strength.
- Balance sheet: total debt $2.40B, cash $2.01B → net debt just $0.39B, net-debt/EBITDA 0.21×, debt-to-capital 12.3%, current ratio 5.5×. This is one of the least-levered balance sheets in the sector — the reason downside risk scores below the cyclical average.
6. Valuation — priced in or room?
On trailing numbers PHM looks cheap: 12.5× TTM EPS, 9.3× EV/EBITDA, 1.5× EV/sales, 2.0× book. The trap is that homebuilder P/Es are supposed to look cheap near an earnings peak — the "E" is elevated and about to fall. On forward estimates the multiple actually rises then falls with the earnings dip and recovery: 13.4× FY26E → 12.0× FY27E → 10.1× FY28E. So you are not buying a shrinking multiple on rising earnings (the good kind); you are buying a low multiple on trough-ish earnings and betting on the cycle turning.
A book-value read gives the downside floor: tangible book ~$67/share means the stock trades at ~2.0× book — rich versus deep-downturn homebuilder troughs (which have touched ~1× book), so book value is a distant floor, not a near one. Street targets (context): consensus $144.5, high $162, low $115, with a Hold rating (0 Strong-Buy, 20 Buy, 21 Hold, 3 Sell). Our $134 base FV is below consensus because we don't yet credit a full recovery multiple while gross margin is still compressing. Not a clear value buy; a fair-to-fully-priced cyclical.
7. Technicals (from the tech block)
- Trend: up. $133.67 sits above the 50-DMA ($121.9) and 200-DMA ($124.5), with the 50 back above the 200 — a constructive posture. MACD +4.44 (positive).
- Location: −6.2% off the 52-week high ($142.56) and +23.8% off the 52-week low ($108) — upper half of the range, moderate max drawdown (−10.3% from peak).
- Momentum: RSI(14) 65.5 — strong, approaching but not yet overbought (<70).
- Relative strength: PHM +21.6% 12-mo vs SPY +20.6% (roughly in line) but lagging QQQ +30.3%; +14.1% 3-mo vs SPY +13.7%. A market-performer, not a leader.
- Read: technicals are constructive and do not argue for urgency in either direction. Price near the upper range with a full valuation is consistent with the Watch call — a pullback toward the rising 50-DMA (~$122) would offer a better risk/reward entry for a cyclical value buyer.
8. Moat & competitive position
Homebuilding is a structurally low-moat, commoditized, cyclical industry — the "moat" is relative: scale in land acquisition, a national brand portfolio spanning buyer segments (entry-level Centex to active-adult Del Webb), an even-flow production discipline, and a low-cost balance sheet that lets PHM keep buying land and buying back stock when weaker builders retrench. Del Webb (55+ active-adult) is a genuine differentiator with demographic tailwinds. But there is no pricing power against the macro: when rates rise, everyone discounts.
Peer set (FMP-supplied — note it is a mixed consumer-cyclical basket, not pure homebuilders): true comps are Lennar $21.9B, NVR $18.2B, Toll Brothers $14.7B; the list also includes non-homebuilders (Darden $23.4B, Restaurant Brands $25.9B, Ulta $19.8B, Williams-Sonoma $26.8B, Geely, XPeng) grouped only by market cap / consumer-cyclical sector. Against the real homebuilder comps, PHM is mid-to-large, best-in-class on balance-sheet quality, and valued in line with the group.
9. Management, capital allocation & guidance
- Capital allocation (the strength): exemplary for a cyclical. FY25 repurchased $1.22B of stock (~4.8% of the current cap) plus $177M dividends; Q1'26 repurchased $308M at ~$127/share and the Board added $1.5B to the buyback authorization (bringing remaining to $2.1B). Debt-to-capital held at 12.3%. Management is shrinking the share count into weakness — the textbook cyclical playbook.
- Insider activity: the sampled window shows routine director equity awards and small officer sales / tax-withholding ("F-InKind") dispositions — e.g., COO Koart sold 7,457 shares at $120 (2026-05-27) and a director sold 3,339 at $117.18. Nothing that reads as a coordinated alarming exit; ordinary compensation-driven flow.
- Management's own guidance (the earnings-release track — half-weighted, self-interested): From the SEC 8-K (Q1'26 earnings release, filed 2026-04-23), CEO Ryan Marshall's own words: net new orders +3% to 8,034 homes ($4.6B value), backlog 10,427 homes / $6.5B, and a demand environment with "a consumer with concerns about affordability and the economy, but still desirous of homeownership." Management says it "continue[s] to intelligently manage sales, incentives and production" — i.e., defending margin and returns over volume. The release contains no explicit numeric full-year revenue/EPS guidance (homebuilders typically guide on closings, ASP, gross margin, and community count on the call rather than in the release). Treat this as management's self-interested framing, half-weighted; the honest read is that management is signalling a managed slowdown, not growth.
10. Catalysts & what to watch
- Next earnings: 2026-07-22 (Q2'26; Street EPS $2.38, revenue ~$3.95B). The lines that matter: home-sale gross margin (is the 24.4% erosion stabilizing?), net new orders (demand pulse), and incentive levels.
- Mortgage rates / Fed path: the single biggest external swing factor for both volume and margin.
- Gross-margin trajectory: two more quarters of compression would confirm the bear path; stabilization would support the base/bull.
- Buyback pace: continued aggressive repurchase near/below book supports per-share value even in a flat market.
- Backlog and community count: backlog was $6.5B and average communities +9% YoY — watch whether that converts to closings or gets discounted.
Thesis tripwires (what would change the call): gross margin breaking below ~23%; net new orders turning negative YoY; a mortgage-rate spike; or, on the upside, rate relief + margin stabilization that would flip this from Watch to a tactical Buy on the cheap multiple.
11. Key risks
- Housing cyclicality (structural, dominant): rates and affordability drive volumes and margins together; the cycle has already rolled over (EPS −24% FY24→FY25, GM −310bp YoY).
- Margin compression: rising incentives to clear spec inventory are eroding the best part of the P&L; if it persists, forward estimates fall.
- Geographic concentration: heavy Florida/Sun Belt exposure ties results to regional affordability, insurance-cost, and property-tax pressures.
- Value-trap risk: a low P/E on falling earnings can stay "cheap" for a long time and still lose money.
- No expert coverage / thin external validation: unlike our conviction names, no tracked expert panel is underwriting this thesis — the call rests entirely on quant + fundamentals.
- Rate-sensitivity of the mortgage arm: small, but Financial Services pre-tax income already fell to $13M (Q1'26) from $36M a year ago.
12. Verdict, position sizing & monitoring
Watch. PulteGroup is a genuinely well-run homebuilder — fortress balance sheet (net-debt/EBITDA 0.21×), strong FCF (~$1.75B), high returns (16% ROE), and disciplined, aggressive buybacks — trading at a cheap-looking 12.5× TTM. But it is a deep cyclical at the wrong end of its earnings cycle: EPS fell to $11.21 from $14.82, gross margin compressed 310bp YoY, and FY26 estimates call for a further ~11% EPS decline before a FY27–28 recovery. Our base-case fair value (~$134) sits essentially at spot and below the Street's $144.5 — there is no clear margin of safety today, and no expert conviction in the KB to lean on.
- Sizing: if owned at all, a small cyclical/value satellite (~1–2%), sized to survive a housing downturn — not a core holding. A better entry would be a pullback toward the ~$122 50-DMA or evidence of margin stabilization.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-07-22). Flip to Buy — Tactical on rate relief + gross-margin stabilization; flip to Avoid on GM below ~23% with negative orders.
- Single biggest risk: the housing cycle — rates and affordability squeezing volume and margin simultaneously, which is already underway.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of PHM in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven; no conviction is borrowed or fabricated (claim-ID reconciliation makes fabrication structurally impossible).
- Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from SEC 8-K filed 2026-04-23. Forward figures are analyst consensus (FMP) or our own scenario model, labeled as estimates.
- Management caveat: the §9 guidance is management's own earnings-release language, half-weighted by design; the release contained no explicit numeric full-year EPS/revenue guidance.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").